SGS Life Science Services wins European Outsourcing Award for Best Contract Analytical Project at CPhI Worldwide 2010
SGS’s Life Science Services division is pleased to announce that it received the European Outsourcing Award for ‘Best Contract Analytical Project’. The European Outsourcing Awards, presented annually, are sponsored by Via Media, publishers of Pharma Magazine. The awards recognize outstanding achievements of outsourcing providers in 10 categories ranging from "Most Improved Process/Plant Facility" to "Most Effective Tech Transfer/Scale Up". For each category, three finalists were identified by a panel of judges representing various facets of the bio/pharmaceutical industry. Winners were announced in Paris at a gala dinner and awards ceremony held during CPhI Worldwide, one of the largest expositions for the pharmaceutical industry.
The winning submission from SGS involved its new service for Gas Analysis, an area which has been the subject of recent regulatory focus. Industrial gases are employed in many processes in the manufacture of pharmaceuticals and drug producers must fulfill cGMP requirements in order to assure batch uniformity and integrity of the drug product. SGS was approached by one of its large pharmaceutical clients to develop the new service and deliver qualified and validated methods within 6 months.
“SGS is honored to receive the European Outsourcing Award for Best Contract Analytical Project”, said Anne Hays, Executive Vice President for the Life Science Services business. “At SGS, we strive to not only serve our customers needs today, but to respond to their demands as their needs and the regulatory requirements evolve. The new service for Gas Analysis, for which we received the award, is demonstrative of this spirit and was a team effort between laboratories within our network.”
With 13 laboratories offering contract analytical services, SGS leverages its strong global network to deliver harmonized, solutions to large pharmaceutical and biotechnology firms. In addition to testing services for the pharmaceutical market, SGS also offers provides clinical trial management (Phase I to IV) and services encompassing bioequivalence studies, bioanalytical services, data management, pharmacovigilance and regulatory consultancy.
The SGS Group is the global leader and innovator in inspection, verification, testing and certification services. Founded in 1878, SGS is recognised as the global benchmark in quality and integrity. With 59,000 employees, SGS operates a network of over 1,000 offices and laboratories around the world.